5 reports of this reaction
3.4% of all ALUMINUM CHLOROHYDRATE reports
#2 most reported adverse reaction
MACULE is the #2 most commonly reported adverse reaction for ALUMINUM CHLOROHYDRATE, manufactured by The Procter & Gamble Manufacturing Company. There are 5 FDA adverse event reports linking ALUMINUM CHLOROHYDRATE to MACULE. This represents approximately 3.4% of all 148 adverse event reports for this drug.
Patients taking ALUMINUM CHLOROHYDRATE who experience macule should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MACULE is moderately reported among ALUMINUM CHLOROHYDRATE users, representing a notable but not dominant share of adverse events.
In addition to macule, the following adverse reactions have been reported for ALUMINUM CHLOROHYDRATE:
The following drugs have also been linked to macule in FDA adverse event reports:
MACULE has been reported as an adverse event in 5 FDA reports for ALUMINUM CHLOROHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MACULE accounts for approximately 3.4% of all adverse event reports for ALUMINUM CHLOROHYDRATE, making it one of the most commonly reported side effect.
If you experience macule while taking ALUMINUM CHLOROHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.